Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764829 · ClinicalTrials.gov registry record
Blood Samples to Evaluate Biomarkers of Donor Chimerism
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT00764829 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 80 participants.
The verdict
NCT00764829 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
We are interested in patient-specific factors that may affect the balance of recipient cells and donor cells in patients who receive stem cell transplants. We will look at the way the patient's body breaks down two drugs, fludarabine and mycophenolate mofetil, and how these two drugs affect the patient's body.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00764829
The ClinicalTrials.gov registry entry for NCT00764829 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00764829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00764829 about?
NCT00764829 is a clinical study titled "Blood Samples to Evaluate Biomarkers of Donor Chimerism". We are interested in patient-specific factors that may affect the balance of recipient cells and donor cells in patients who receive stem cell transplants. We will look at the way the patient's body breaks down two drugs, fludarabine and mycophenolate mofetil, and how these two drugs affect the pati...
What is the current status of trial NCT00764829?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2008-09. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00764829?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.